AZA
ABBV icon

Arthur Zaske & Associates’s AbbVie ABBV Stock Holding History

Arthur Zaske & Associates’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		$350K Sell
3,619
-811
-18% -$76.4K 0.38% 46
2017
Q3 		$394K Hold
4,430
– – 0.42% 34
2017
Q2 		$321K Hold
4,430
– – 0.28% 43
2017
Q1 		$289K Hold
4,430
– – 0.21% 46
2016
Q4 		$277K Hold
4,430
– – 0.2% 54
2016
Q3 		$279K Buy
+4,430
New +$287K 0.42% 47

Other funds holding ABBV

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
State Farm Mutual Automobile Insurance
State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return

Arthur Zaske & Associates's ABBV Position: Q4 2017 in Review

Arthur Zaske & Associates reduced its AbbVie (ABBV) stake by 18% in Q4 2017, selling an estimated $76.4K and leaving 3,619 shares worth $350K. The position accounts for 0.38% of the portfolio, ranked #46.

Arthur Zaske & Associates first reported a position in ABBV in Q3 2016 and has held it in 6 quarters since. The position peaked at $394K in Q3 2017. 2,001 funds tracked by Wall St. Rank hold ABBV as of Q4 2017.

  • Arthur Zaske & Associates held 3,619 shares of AbbVie worth $350K as of Q4 2017.
  • Arthur Zaske & Associates sold 811 AbbVie shares in Q4 2017, an estimated $76.4K.
  • AbbVie made up 0.38% of Arthur Zaske & Associates's portfolio in Q4 2017, its #46 holding.
  • Arthur Zaske & Associates first reported a position in AbbVie in Q3 2016 and has held it in 6 quarters since.
  • Arthur Zaske & Associates's AbbVie position peaked at $394K in Q3 2017.
  • 2,001 funds tracked by Wall St. Rank held AbbVie as of Q4 2017.

Based on Arthur Zaske & Associates's 13F filing for Q4 2017, filed 14 Feb 2018.